Keywords: india, orchid, sets, up, subsidiary, japan, aim

India's Orchid sets up subsidiary in Japan

Article | 21 April 2008

Print This

With the aim of penetrating the Japanese generics drug market, currently estimated to be worth around $2.5 billion and growing, India's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in